Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 12, 2009, Pages 5279-5283

  Miller, Christopher H ^a   Nisa, Shahista ^a   Dempsey, Sandi ^a   Jack, Cameron ^a   O'Toole, Ronan ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 CHLOROMERCURIBENZOIC ACID; ANTIMYCOBACTERIAL AGENT; CALCIMYCIN; CALMIDAZOLIUM; CAPREOMYCIN; CARBOPLATIN; CIPROFLOXACIN; CISPLATIN; CLOTRIMAZOLE; DEMECLOCYCLINE; DEQUALINIUM; DIPHENYLIODONIUM SALT; DOXYCYCLINE; ETHAMBUTOL; ETHIONAMIDE; IDARUBICIN; LOMEFLOXACIN; METHOCTRAMINE; MINOCYCLINE; MITOXANTRONE; NICLOSAMIDE; OFLOXACIN; PENTAMIDINE; PHENANTHROLINE; RIFAMPICIN; SELENIUM DERIVATIVE; SELENOCYSTEINE; STREPTOMYCIN; TETRACYCLINE;

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; MYCOBACTERIUM; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; SCREENING;

ANTITUBERCULAR AGENTS; CYSTEINE; DRUG EVALUATION, PRECLINICAL; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; ORGANOSELENIUM COMPOUNDS; SMALL MOLECULE LIBRARIES;

EID: 71249119558     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00803-09     Document Type: Article

References (29)

1. Abdulah, R., K. Miyazaki, M. Nakazawa, and H. Koyama. 2005. Chemical forms of selenium for cancer prevention. J. Trace Elem. Med. Biol. 19:141-150.
2. Anton, V., P. Rouge, and M. Daffe. 1996. Identification of the sugars involved in mycobacterial cell aggregation. FEMS Microbiol. Lett. 144:167-170.
3. Benn, C. S., H. Friis, and C. Wejse. 2008. Should micronutrient supplementation be integrated into the case management of tuberculosis? J. Infect. Dis. 197:1487-1489.
4. Betts, J. C., P. T. Lukey, L. C. Robb, R. A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43: 717-731.
5. Bourn, W. R., Y. Jansen, H. Stutz, R. M. Warren, A. L. Williamson, and P. D. van Helden. 2007. Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial replicon. Tuberculosis (Edinburgh) 87:481-488.
6. Burguiere, A., P. G. Hitchen, L. G. Dover, A. Dell, and G. S. Besra. 2005. Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole. Microbiology 151:2087-2095. (Pubitemid 40909050)
7. Changsen, C., S. G. Franzblau, and P. Palittapongarnpim. 2003. Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter. Antimicrob. Agents Chemother. 47:3682-3687.
8. Chocat, P., N. Esaki, T. Nakamura, H. Tanaka, and K. Soda. 1983. Microbial distribution of selenocysteine lyase. J. Bacteriol. 156:455-457.
9. Collins, H. L., U. E. Schaible, and S. H. Kaufmann. 1998. Early IL-4 induction in bone marrow lymphoid precursor cells by mycobacterial lipoarabinomannan. J. Immunol. 161:5546-5554.
10. Collins, L., and S. G. Franzblau. 1997. Microplate alamar blue assay versus BACTEC 460 system for high-throughout screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41:1004-1009. (Pubitemid 27194176)
11. Cormack, B. P., R. H. Valdivia, and S. Falkow. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38. (Pubitemid 26239677)
12. Gordhan, B. G., D. A. Smith, H. Alderton, R. A. McAdam, G. J. Bancroft, and V. Mizrahi. 2002. Construction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis. Infect. Immun. 70:3080-3084.
13. Hampshire, T., S. Soneji, J. Bacon, B. W. James, J. Hinds, K. Laing, R. A. Stabler, P. D. Marsh, and P. D. Butcher. 2004. Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms? Tuberculosis (Edinburgh) 84:228-238.
14. Hondalus, M. K., S. Bardarov, R. Russell, J. Chan, W. R. Jacobs, Jr., and B. R. Bloom. 2000. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 68:2888-2898.
15. Jackson, M. I., and G. F. Combs, Jr. 2008. Selenium and anticarcinogenesis: underlying mechanisms. Curr. Opin. Clin. Nutr. Metab. Care 11:718-726.
16. Kenney, T. J., and G. Churchward. 1996. Genetic analysis of the Mycobacterium smegmatis rpsL promoter. J. Bacteriol. 178:3564-3571.
17. Ligges, U., and M. Machler. 2003. Scatterplot3d - an R package for visualizing multivariate data. J. Stat. Software 8:1-20. (Pubitemid 39234619)
18. O'Toole, R., M. J. Smeulders, M. C. Blokpoel, E. J. Kay, K. Lougheed, and H. D. Williams. 2003. A two-component regulator of universal stress protein expression and adaptation to oxygen starvation in Mycobacterium smegmatis. J. Bacteriol. 185:1543-1554. (Pubitemid 36245956)
19. O'Toole, R., J. Von Hofsten, R. Rosqvist, P. E. Olsson, and H. Wolf-Watz. 2004. Visualisation of zebrafish infection by GFP-labelled Vibrio anguillarum. Microb. Pathog. 37:41-46.
20. Parish, T., and N. G. Stoker. 1998. Mycobacteria protocols. Humana Press, Totowa, NJ.
21. Smeulders, M. J., J. Keer, R. A. Speight, and H. D. Williams. 1999. Adaptation of Mycobacterium smegmatis to stationary phase. J. Bacteriol. 181:270-283.
22. Sun, Z., and Y. Zhang. 1999. Antituberculosis activity of certain antifungal and antihelmintic drugs. Tuber. Lung. Dis. 79:319-320.
23. Suzuki, K. T., K. Kurasaki, and N. Suzuki. 2007. Selenocysteine beta-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide. Biochim. Biophys. Acta 1770:1053-1061.
24. Villamor, E., F. Mugusi, W. Urassa, R. J. Bosch, E. Saathoff, K. Matsumoto, S. N. Meydani, and W. W. Fawzi. 2008. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J. Infect. Dis. 197:1499-1505.
25. World Health Organization. 2006. The Global Plan to Stop TB 2006-2015. Actions for life: towards a world free of tuberculosis. World Health Organization and Stop TB Partnership. World Health Organization publication no. WHO/HTM/STB/2006.35. World Health Organization, Geneva, Switzerland.
26. World Health Organization. 2008. Anti-tuberculosis drug resistance in the world, report no. 4. Fourth global report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. World Health Organization publication no. WHO/HTM/TB/2008.394. World Health Organization, Geneva, Switzerland.
27. World Health Organization. 2008. Global tuberculosis control- surveillance, planning, financing. WHO Report 2008. World Health Organization publication no. WHO/HTM/TB/2008.393. World Health Organization, Geneva, Switzerland.
28. World Health Organization. 2009. Global tuberculosis control- epidemiology, strategy, financing. WHO Report 2009. World Health Organization publication no. WHO/HTM/TB/2009.411. World Health Organization, Geneva, Switzerland.
29. Zhang, J. H., T. D. Chung, and K. R. Oldenburg. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73.